IGIV Study for Chronic ITP Patients Ages 3-70
Public ClinicalTrials.gov record NCT00511147. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Prospective, Open-label, Clinical Trial to Assess the Safety and the Efficacy of a New Intravenous Immune Globulin (IGIV3I Grifols 10%) in Patients With Idiopathic (Immune) Thrombocytopenic Purpura
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Idiopathic (immune) thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by platelet destruction and thrombocytopenia (peripheral blood platelet count \< 150 x 10\^9/L). IVIG therapy is useful in patients in whom the platelet count has to be raised either due to bleeding signs, or where bleeding is predicted (e.g., surgery or parturition). The primary goal of treatment is to maintain the platelet count at a hemostatic level. This study will test the safety and efficacy of IGIV3I Grifols 10% in the treatment of patients with chronic ITP.
Study identification
- NCT ID
- NCT00511147
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 3 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2008 (Type not available)
- Primary completion
- Apr 2014 (Actual)
- Completion
- Apr 2014 (Actual)
- Last update posted
- Jun 12, 2017
2008 – 2014
United States locations
- U.S. sites
- 31
- U.S. states
- 18
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Phoenix Children's Hospital | Phoenix | Arizona | 85061 | — |
| Scottsdale Medical Specialists | Scottsdale | Arizona | 85258 | — |
| Arizona Oncology Associates | Tucson | Arizona | 85745 | — |
| Scripps Cancer Center | La Jolla | California | 92037 | — |
| Kenmar Research Institute, LLC | Los Angeles | California | 90057 | — |
| Children's Hospital of Orange County | Orange | California | 92868 | — |
| Connecticut Children's Medical Center | Hartford | Connecticut | 06106 | — |
| Cancer Center of Central Connecticut | Southington | Connecticut | 06489 | — |
| Georgetown University | Washington D.C. | District of Columbia | 20007 | — |
| VA Medical Center | Washington D.C. | District of Columbia | 20422 | — |
| Halifax Health Medical Center | Daytona Beach | Florida | 32114 | — |
| Hematology Oncology Associates | Lake Worth | Florida | 33461 | — |
| Lakeland Regional Cancer Center | Tampa | Florida | 33607-6307 | — |
| St. Joseph's Children's Hospital of Tampa | Tampa | Florida | 33607-6307 | — |
| Cleveland Clinic Florida | Weston | Florida | 33331 | — |
| Emory University School of Medicine Winship Cancer Center | Atlanta | Georgia | 30322 | — |
| Advocate Hope Children's Hospital | Oak Lawn | Illinois | 60453 | — |
| University of Iowa Children's Hospital | Iowa City | Iowa | 52242 | — |
| Children's Hospital | New Orleans | Louisiana | 70118 | — |
| Kalamazoo Hematology & Oncology | Kalamazoo | Michigan | 49048 | — |
| CTO Breslin Cancer Center/MSU/Great Lakes Cancer Institute | Lansing | Michigan | 48910 | — |
| University of Mississippi | Jackson | Mississippi | 39216 | — |
| Capital Comprehensive Cancer Care Clinic | Jefferson City | Missouri | 65109 | — |
| UMDNJ-RWJ Medical School | New Brunswick | New Jersey | 08901 | — |
| Mt. Sinai Medical Center | New York | New York | 10029 | — |
| Children's Hospital, University of Oklahoma | Oklahoma City | Oklahoma | 73104 | — |
| Western Pennsylvannia Hospital | Pittsburgh | Pennsylvania | 15224 | — |
| Baptist Cancer Center | Beaumont | Texas | 77705 | — |
| Cook Children's Medical Center | Fort Worth | Texas | 76104 | — |
| Tyler Hematology Oncology PA | Tyler | Texas | 75701 | — |
| MCV Hospital | Richmond | Virginia | 23298 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00511147, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2017 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00511147 live on ClinicalTrials.gov.